These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10981154)

  • 1. Review of recent Framingham study hypertension research.
    Kannel WB
    Curr Hypertens Rep; 2000 Jun; 2(3):239-40. PubMed ID: 10981154
    [No Abstract]   [Full Text] [Related]  

  • 2. Ventricular repolarization in hypertension: beyond Bazett.
    Passino C; Emdin M
    Am J Hypertens; 2008 Jan; 21(1):9. PubMed ID: 18091736
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension and the heart.
    Lip GY; Gammage MD; Beevers DG
    Br Med Bull; 1994 Apr; 50(2):299-321. PubMed ID: 8205460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood pressure goal and choice of antihypertensive treatment in patients with mild hypertensive cardiovascular disease].
    Narumi H; Takano H; Komuro I
    Nihon Rinsho; 2008 Aug; 66(8):1566-73. PubMed ID: 18700559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension: goal systolic and diastolic blood pressure.
    Weir MR
    Curr Hypertens Rep; 1999 Oct; 1(5):411-3. PubMed ID: 10981098
    [No Abstract]   [Full Text] [Related]  

  • 6. Reducing hypertension-associated cardiorenal risk: the role of heart rate, left ventricular hypertrophy regression, and renoprotection.
    Materson BJ
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):1S-2S. PubMed ID: 10077412
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval?
    Salles GF; Cardoso CR; Leocadio SM; Muxfeldt ES
    Am J Hypertens; 2008 Jan; 21(1):47-53. PubMed ID: 18091743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypertensive heart: new observations and evolving therapeutic imperatives.
    Setaro JF
    J Clin Hypertens (Greenwich); 2001; 3(1):14-5. PubMed ID: 11416676
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypertensive heart disease--significance of left ventricular hypertrophy.
    Schmieder RE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?
    Lip GY; Felmeden DC; Li-Saw-Hee FL; Beevers DG
    Eur Heart J; 2000 Oct; 21(20):1653-65. PubMed ID: 11032692
    [No Abstract]   [Full Text] [Related]  

  • 11. [Arterial hypertension and heart insufficiency].
    Schwartzkopff B; Mundhenke M; Strauer BE
    Internist (Berl); 2000 Mar; 41(3):253-60. PubMed ID: 10789088
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
    Baumgart P
    MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
    [No Abstract]   [Full Text] [Related]  

  • 13. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
    Fyhrquist F; Dahlöf B; Devereux RB; Kjeldsen SE; Julius S; Beevers G; de Faire U; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Hille DA; Lyle PA; Edelman JM; Snapinn SM; Wedel H;
    Hypertension; 2005 Apr; 45(4):580-5. PubMed ID: 15790960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated systolic hypertension and the risk of vascular disease.
    Nawrot T; Den Hond E; Thijs L; Staessen JA
    Curr Hypertens Rep; 2003 Oct; 5(5):372-9. PubMed ID: 12948429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a dual L/N-type calcium channel blocker cilnidipine on blood pressure, pulse rate, and autonomic functions in patients with mild to moderate hypertension.
    Kai T; Kuzumoto Y
    Clin Exp Hypertens; 2009 Oct; 31(7):595-604. PubMed ID: 19886857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary reserve and arteriolosclerosis in hypertensive heart disease.
    Schwartzkopff B; Strauer BE
    Z Kardiol; 2000; 89 Suppl 9():IX/132-5. PubMed ID: 11151783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diastolic dysfunction in hypertensive left ventricular hypertrophy.
    Bella JN
    Am J Hypertens; 2006 Sep; 19(9):937-8. PubMed ID: 16942936
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of 4 month exercise on left ventricular remodeling and autonomic nervous system in hypertensive patients.
    Zheng H; Xie N; Xu H; Huang J; Xie X; Luo M
    Panminerva Med; 2016 Mar; 58(1):1-7. PubMed ID: 25288325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.